M&T Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

M&T Bank’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,397	Closed	-$233K	–	1793
2016 Q1	$233K	Buy	11,397 +5,033	+79%	+$160K	﹤0.01%	1398
2015 Q4	$328K	Sell	6,364 -1,905	-23%	-$92.4K	﹤0.01%	1252
2015 Q3	$352K	Sell	8,269 -8,018	-49%	-$387K	﹤0.01%	1239
2015 Q2	$742K	Buy	+16,287	New	+$655K	﹤0.01%	1012
2014 Q2	–	Sell	-57	Closed	-$1K	–	1195
2014 Q1	$1K	Buy	+57	New	+$1.52K	﹤0.01%	1196

Other funds holding PTLA

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

M&T Bank's PTLA Position: Q2 2016 in Review

M&T Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2016, closing a stake of 11,397 shares — an estimated $233K sold.

M&T Bank first reported a position in PTLA in Q1 2014 and held it in 5 quarters. The position peaked at $742K in Q2 2015. 159 funds tracked by Wall St. Rank hold PTLA as of Q2 2016.

M&T Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
M&T Bank sold 11,397 Portola Pharmaceuticals, Inc. shares in Q2 2016, an estimated $233K.
M&T Bank first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 5 quarters.
M&T Bank's Portola Pharmaceuticals, Inc. position peaked at $742K in Q2 2015.
159 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2016.

Based on M&T Bank's 13F filing for Q2 2016, filed 4 Aug 2016.